TRIM29 and colorectal carcinoma: To further verify that TRIM29-mediated EMT in CRC is regulated by the Wnt/β-catenin signaling pathway, we use a pharmacological inhibitor of the Wnt/β-catenin signaling pathway to examine the effects of TRIM29.